EcoDrugPlus

Vitamin D Receptor

Ensembl ID : ENSPFOG00000014233
Gene Symbol: VDR
3 Cross references
388 Possible Orthologues:

Vitamin K Epoxide Reductase Complex, Subunit 1

Ensembl ID : ENSPFOG00000004704
Gene Symbol: VKORC1
1 Cross references
190 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-3 Subunit-Like

Ensembl ID : ENSPFOG00000000868
Gene Symbol: LOC103132652
2 Cross references
190 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSPFOG00000007865
Gene Symbol: LOC103146434
3 Cross references
167 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSPFOG00000011804
Gene Symbol: LOC103141690
3 Cross references
189 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-6 Subunit-Like

Ensembl ID : ENSPFOG00000007911
Gene Symbol: LOC103146435
3 Cross references
182 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-7 Subunit-Like

Ensembl ID : ENSPFOG00000007821
Gene Symbol: LOC103146433
3 Cross references
184 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSPFOG00000006876
Gene Symbol: XDH
3 Cross references
208 Possible Orthologues:

Ensembl ID : ENSPFOG00000017356
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSPFOG00000017594
Gene Symbol: PDGFRA
1 Cross references
203 Possible Orthologues:

Ensembl ID : ENSPFOG00000013494
Gene Symbol: -
Cross references: -
219 Possible Orthologues:

Ensembl ID : ENSPFOG00000013762
Gene Symbol: -
Cross references: -
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).